Luigi Mangione confessed in court on Friday to shooting and killing health insurance executive Brian Thompson, pleading guilty to two federal charges of stalking with the intent to kill. Mangione, dressed in beige prison attire, spoke calmly and clearly as he acknowledged his actions, criticizing the U.S. health insurance system.
Thompson’s widow, accompanied by family members, emotionally reacted as Mangione admitted to the shooting. The guilty plea spares Mangione from a federal trial in the high-profile case involving the death of the 50-year-old UnitedHealthcare CEO, a crime that sparked public outrage and highlighted frustrations with the health insurance industry.
Despite pleading guilty without a plea deal, Mangione faces a potential life sentence as federal prosecutors seek the maximum penalty at his sentencing on December 18. U.S. District Judge Margaret Garnett may consider his guilty plea as a mitigating factor in sentencing.
Mangione’s admission also allowed his defense team to request the dismissal of state murder and weapons charges, arguing against double jeopardy under New York law. Manhattan U.S. Attorney Jamie McDonald emphasized that no concessions were made to Mangione, reiterating that no grievance justifies murder.
Thompson’s family viewed the guilty plea as a step towards justice, urging the court to ensure the severity of the crime is reflected in the sentencing. The tragic incident occurred in December 2024 when Thompson, a prominent figure in UnitedHealth Group, was fatally shot outside a hotel during an investor conference.
Mangione detailed his actions leading up to the incident, including fabricating his identity to gain access to Thompson and constructing a weapon using a 3D printer. UnitedHealth Group expressed gratitude to law enforcement for apprehending the perpetrator.
Mangione had initially pleaded not guilty to federal charges in April 2025, but legal technicalities led to the dismissal of murder and weapons charges in January 2026, sparing him from the death penalty. He also faces separate state charges which are set for trial in September, with potential implications under New York’s double jeopardy law.
The case has generated significant media attention and legal complexities, with defense lawyers and prosecutors grappling over the interpretation of various charges. The upcoming trial will determine Mangione’s fate in the state case, with legal experts highlighting the intricacies of the charges and potential arguments in court.